Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Dec;60(6):887–892. doi: 10.1038/bjc.1989.385

A novel hybridoma antibody (PASE/4LJ) to human prostatic acid phosphatase suitable for immunohistochemistry.

A M Haines 1, S E Larkin 1, A P Richardson 1, R W Stirling 1, E Heyderman 1
PMCID: PMC2247265  PMID: 2605098

Abstract

A murine monoclonal antibody PASE/4LJ to prostatic acid phosphatase (PAP) was used to immunostain a wide variety of sections of benign and malignant tissues (654 blocks). Non-neoplastic adult and fetal prostatic glands, primary and metastatic prostatic carcinomas, and scattered cells in prostatic and penile urethra were positive. Rat, dog and rabbit prostates were negative. Nine of 400 tumours of non-prostatic origin showed some positivity: 6/36 carcinoids, 1/9 islet cell tumours, 1/55 ovarian adenocarcinomas (serous) and one carcinosarcoma of the lung (epithelial portion). Positive staining was seen in islet cells in 4/5 specimens of normal pancreas, and in 4/9 blocks of normal pancreas surrounding a pancreatic tumour. Loops of Henle, maculae densae, and distal tubules in 10/10 fetal and 2/9 adult kidneys were also positive, with proximal tubules and collecting ducts negative. All other 159 blocks of non-neoplastic adult and fetal tissues were negative. The antibody was also affinity purified from ascitic fluid, and shown not to inhibit the enzyme activity of prostatic acid phosphatase.

Full text

PDF
890

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABUL-FADL M. A. M., KING E. J. Properties of the avid phosphatases of erythrocytes and of human prostate gland. Biochem J. 1949;45(1):51–60. [PubMed] [Google Scholar]
  2. Allhoff E. P., Proppe K. H., Chapman C. M., Lin C. W., Prout G. R., Jr Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer. J Urol. 1983 Feb;129(2):315–318. doi: 10.1016/s0022-5347(17)52074-1. [DOI] [PubMed] [Google Scholar]
  3. Almagro U. A., Tieu T. M., Remeniuk E., Kueck B., Strumpf K. Argyrophilic, 'carcinoid-like' prostatic carcinoma. An immunocytochemical study. Arch Pathol Lab Med. 1986 Oct;110(10):916–919. [PubMed] [Google Scholar]
  4. Ansari M. A., Pintozzi R. L., Choi Y. S., Ladove R. F. Diagnosis of carcinoid-like metastatic prostatic carcinoma by an immunoperoxidase method. Am J Clin Pathol. 1981 Jul;76(1):94–98. doi: 10.1093/ajcp/76.1.94. [DOI] [PubMed] [Google Scholar]
  5. BARKA T. A simple azo-dye method for histochemical demonstration of acid phosphatase. Nature. 1960 Jul 16;187:248–249. doi: 10.1038/187248a0. [DOI] [PubMed] [Google Scholar]
  6. Burns J. Prostatic acid phosphatase in tissue sections revealed by the unlabelled antibody peroxidase-antiperoxidase method. Biomedicine. 1977 Jan 31;27(1):7–10. [PubMed] [Google Scholar]
  7. Choe B. K., Pontes E. J., Rose N. R., Henderson M. D. Expression of human prostatic acid phosphatase in a pancreatic islet cell carcinoma. Invest Urol. 1978 Jan;15(4):312–318. [PubMed] [Google Scholar]
  8. Cohen C., Bentz M. S., Budgeon L. R. Prostatic acid phosphatase in carcinoid and islet cell tumors. Arch Pathol Lab Med. 1983 May;107(5):277–277. [PubMed] [Google Scholar]
  9. Cordell J., Richardson T. C., Pulford K. A., Ghosh A. K., Gatter K. C., Heyderman E., Mason D. Y. Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer. 1985 Sep;52(3):347–354. doi: 10.1038/bjc.1985.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Frankel A. E., Rouse R. V., Herzenberg L. A. Human prostate specific and shared differentiation antigens defined by monoclonal antibodies. Proc Natl Acad Sci U S A. 1982 Feb;79(3):903–907. doi: 10.1073/pnas.79.3.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Frankel A. E., Rouse R. V., Wang M. C., Chu T. M., Herzenberg L. A. Monoclonal antibodies to a human prostate antigen. Cancer Res. 1982 Sep;42(9):3714–3718. [PubMed] [Google Scholar]
  12. Garvin A. J., Spicer S. S., Parmley R. T., Munster A. M. Immunohistochemical demonstration of IgG in Reed-Sternberg and other cells in Hodgkin's disease. J Exp Med. 1974 May 1;139(5):1077–1083. doi: 10.1084/jem.139.5.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gieselmann V., Hasilik A., von Figura K. Tartrate-inhibitable acid phosphatase. Purification from placenta, characterization and subcellular distribution in fibroblasts. Hoppe Seylers Z Physiol Chem. 1984 Jun;365(6):651–660. doi: 10.1515/bchm2.1984.365.1.651. [DOI] [PubMed] [Google Scholar]
  14. Heyderman E., Brown B. M., Richardson T. C. Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase. J Clin Pathol. 1984 Dec;37(12):1363–1369. doi: 10.1136/jcp.37.12.1363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Heyderman E., Mandaliya K. N., O'Donnell P. J., Kadow C., Bultitude M. I. Ectopic prostatic glands in bulbar urethra. Immunoperoxidase study. Urology. 1987 Jan;29(1):76–77. doi: 10.1016/0090-4295(87)90606-6. [DOI] [PubMed] [Google Scholar]
  16. Heyderman E., Strudley I., Powell G., Richardson T. C., Cordell J. L., Mason D. Y. A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2. Br J Cancer. 1985 Sep;52(3):355–361. doi: 10.1038/bjc.1985.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  18. Jöbsis A. C., De Vries G. P., Anholt R. R., Sanders G. T. Demonstration of the prostatic origin of metastases: an immunohistochemical method for formalin-fixed embedded tissue. Cancer. 1978 May;41(5):1788–1793. doi: 10.1002/1097-0142(197805)41:5<1788::aid-cncr2820410521>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  19. Jöbsis A. C., De Vries G. P., Meijer A. E., Ploem J. S. The immunohistochemical detection of prostatic acid phosphatase: its possibilities and limitations in tumour histochemistry. Histochem J. 1981 Nov;13(6):961–973. doi: 10.1007/BF01002636. [DOI] [PubMed] [Google Scholar]
  20. Keillor J. S., Aterman K. The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study. J Urol. 1987 May;137(5):894–896. doi: 10.1016/s0022-5347(17)44288-1. [DOI] [PubMed] [Google Scholar]
  21. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  22. Li C. Y., Lam W. K., Yam L. T. Immunohistochemical diagnosis of prostatic cancer with metastasis. Cancer. 1980 Aug 15;46(4):706–712. doi: 10.1002/1097-0142(19800815)46:4<706::aid-cncr2820460412>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  23. Li C. Y., Yam L. T., Lam K. W. Studies of acid phosphatase isoenzymes in human leukocytes demonstration of isoenzyme cell specificity. J Histochem Cytochem. 1970 Dec;18(12):901–910. doi: 10.1177/18.12.901. [DOI] [PubMed] [Google Scholar]
  24. McEntee M., Isaacs W., Smith C. Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens. Prostate. 1987;11(2):163–170. doi: 10.1002/pros.2990110207. [DOI] [PubMed] [Google Scholar]
  25. Saini M. S., Van Etten R. L. A homogeneous isoenzyme of human liver acid phosphatase. Arch Biochem Biophys. 1978 Dec;191(2):613–624. doi: 10.1016/0003-9861(78)90399-5. [DOI] [PubMed] [Google Scholar]
  26. Shah N. T., Tuttle S. E., Strobel S. L., Gandhi L. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material. J Surg Oncol. 1985 Aug;29(4):265–268. doi: 10.1002/jso.2930290416. [DOI] [PubMed] [Google Scholar]
  27. Sobin L. H., Hjermstad B. M., Sesterhenn I. A., Helwig E. B. Prostatic acid phosphatase activity in carcinoid tumors. Cancer. 1986 Jul 1;58(1):136–138. doi: 10.1002/1097-0142(19860701)58:1<136::aid-cncr2820580124>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  28. Stamey T. A., Yang N., Hay A. R., McNeal J. E., Freiha F. S., Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987 Oct 8;317(15):909–916. doi: 10.1056/NEJM198710083171501. [DOI] [PubMed] [Google Scholar]
  29. Van Etten R. L., Saini M. S. Preparation of homogeneous human prostatic acid phosphatase using concanavalin A-sepharose 4-B. Biochim Biophys Acta. 1977 Oct 13;484(2):487–492. doi: 10.1016/0005-2744(77)90104-8. [DOI] [PubMed] [Google Scholar]
  30. Vernon S. E., Williams W. D. Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostatic specific acid phosphatase and prostatic specific antigen by immunohistochemistry. J Urol. 1983 Jul;130(1):95–98. doi: 10.1016/s0022-5347(17)50977-5. [DOI] [PubMed] [Google Scholar]
  31. Waheed A., Van Etten R. L., Gieselmann V., von Figura K. Immunological characterization of human acid phosphatase gene products. Biochem Genet. 1985 Apr;23(3-4):309–319. doi: 10.1007/BF00504327. [DOI] [PubMed] [Google Scholar]
  32. Wang M. C., Valenzuela L. A., Murphy G. P., Chu T. M. Purification of a human prostate specific antigen. Invest Urol. 1979 Sep;17(2):159–163. [PubMed] [Google Scholar]
  33. Watt K. W., Lee P. J., M'Timkulu T., Chan W. P., Loor R. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sci U S A. 1986 May;83(10):3166–3170. doi: 10.1073/pnas.83.10.3166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Yam L. T., Janckila A. J., Lam W. K., Li C. Y. Immunohistochemistry of prostatic acid phosphatase. Prostate. 1981;2(1):97–107. doi: 10.1002/pros.2990020110. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES